PTH induces bone loss via microbial-dependent expansion of intestinal TNF+ T cells and Th17 cells
Open accessAbstract
Bone loss is a frequent but not universal complication of hyperparathyroidism. Using antibiotic-treated or germ-free mice, we show that parathyroid hormone (PTH) only caused bone loss in mice whose microbiota was enriched by the Th17 cell-inducing taxa segmented filamentous bacteria (SFB). SFB + microbiota enabled PTH to expand intestinal TNF + T and Th17 cells and increase their S1P-receptor-1 mediated egress from the intestine and recruitment to the bone marrow (BM) that causes bone loss. CXCR3-mediated TNF + T cell homing to the BM upregulated the Th17 chemoattractant CCL20, which recruited Th17 cells to the BM. This study reveals mechanisms for microbiota-mediated gut–bone crosstalk in mice models of hyperparathyroidism that may help predict its clinical course. Targeting the gut microbiota or T cell migration may represent therapeutic strategies for hyperparathyroidism.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Th17-inducing organisms such as segmented filamentous bacteria enhance Th17-associated inflammatory signaling and may facilitate osteoclastogenic bone resorption.
“Th17-inducing organisms such as segmented filamentous bacteria enhance Th17-associated inflammatory signaling and may thereby facilitate osteoclastogenic bone resorption [60]”
From Interorgan Communications in Skeletal Pathophysiology: From Molecular Pathways to Multidisciplinary Therapies (2026) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Dempster, D. W., Compston, J. E., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., Recker, R. R., & Parfitt, A. M. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1805 · Cited by 2,543 · see citing works
Ivanov, I. I., Frutos, R. D. L., Manel, N., Yoshinaga, K., Rifkin, D. B., Sartor, R. B., Finlay, B. B., & Littman, D. R. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.09.009 · Cited by 1,770 · see citing works
Interleukin-17 and Type 17 Helper T Cells
Miossec, P., Korn, T., & Kuchroo, V. K. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0707449 · Cited by 1,409 · see citing works
Goto, Y., Panea, C., Nakato, G., Cebula, A., Lee, C., Diez, M. G., Laufer, T. M., Ignatowicz, L., & Ivanov, I. I. (2014) · Immunity · doi:10.1016/j.immuni.2014.03.005 · Cited by 465 · see citing works
The gut-bone axis: How bacterial metabolites bridge the distance
Zaiss, M. M., Jones, R. M., Schett, G., & Pacifici, R. (2019) · Journal of Clinical Investigation · doi:10.1172/jci128521 · Cited by 403 · see citing works
Self-citationThe Th17 family: flexibility follows function
Basu, R., Hatton, R. D., & Weaver, C. T. (2013) · Immunological Reviews · doi:10.1111/imr.12035 · Cited by 229 · see citing works
Flagged first, then by citations
Research works printed but not linked: 54
- [1]Wein, M. N. & Kronenberg, H. M. Regulation of bone remodeling by parathyroid hormone. Cold Spring Harb Perspect Med.8, a031237 (2018). PMC6071549 29358318
- [2]Bilezikian JP Primary hyperparathyroidism J. Clin. Endocrinol. Metab. 2018 103 3993 4004 10.1210/jc.2018-01225 30060226 PMC6182311 · DOI
- [3]Iida-Klein A Short-term continuous infusion of human parathyroid hormone 1-34 fragment is catabolic with decreased trabecular connectivity density accompanied by hypercalcemia in C57BL/J6 mice J. Endocrinol. 2005 186 549 557 10.1677/joe.1.06270 16135674 · DOI
- [4]Potts, J. Primary hyperparathyroidism. in Metabolic Bone Diseases, 1 (Avioli, L. V. & Krane, S. eds.) 411–442 (Academic Press, San Diego, 1998).
- [5]Silverberg SJ Skeletal disease in primary hyperparathyroidism J. Bone Min. Res 1989 4 283 291 10.1002/jbmr.5650040302 2763869 · DOI
- [6]Lips P Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications Endocr. Rev. 2001 22 477 501 10.1210/edrv.22.4.0437 11493580 · DOI
- [7]Pierreux J Bravenboer B Normocalcemic primary hyperparathyroidism: a comparison with the hypercalcemic form in a tertiary referral population Horm. Metab. Res 2018 50 797 802 10.1055/a-0752-4533 30396209 · DOI
- [8]Portillo MR Rodriguez-Ortiz ME Secondary hyperparthyroidism: pathogenesis, diagnosis, preventive and therapeutic strategies Rev. Endocr. Metab. Disord. 2017 18 79 95 10.1007/s11154-017-9421-4 28378123 · DOI
- [9]Messa P Alfieri CM Secondary and tertiary hyperparathyroidism Front Horm. Res 2019 51 91 108 10.1159/000491041 30641516 · DOI
- [10]Xiong J Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency Bone 2014 66C 146 154 10.1016/j.bone.2014.06.006 PMC4125539 24933342 · DOI
- [11]Calvi LM Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone J. Clin. Invest 2001 107 277 286 10.1172/JCI11296 11160151 PMC199196 · DOI · Paper page
- [12]Lanske B Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development J. Clin. Invest 1999 104 399 407 10.1172/JCI6629 10449432 PMC408525 · DOI
- [13]Powell WF Jr. Targeted ablation of the PTH/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses J. Endocrinol. 2011 209 21 32 10.1530/JOE-10-0308 21220409 PMC3783949 · DOI
- [14]Terauchi M T lymphocytes amplify the anabolic activity of parathyroid hormone through Wnt10b signaling Cell Metab. 2009 10 229 240 10.1016/j.cmet.2009.07.010 19723499 PMC2751855 · DOI
- [15]Uzawa T Hori M Ejiri S Ozawa H Comparison of the effects of intermittent and continuous administration of human parathyroid hormone(1-34) on rat bone Bone 1995 16 477 484 7605709
- [16]Gao Y T cells potentiate PTH-induced cortical bone loss through CD40L signaling Cell Metab. 2008 8 132 145 10.1016/j.cmet.2008.07.001 18680714 PMC2569843 · DOI
- [17]Tawfeek H Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss PLoS ONE 2010 5 e12290 10.1371/journal.pone.0012290 20808842 PMC2924900 · DOI
- [18]Li JY IL-17A is increased in humans with primary hyperparathyroidism and mediates PTH-induced bone loss in mice Cell Metab. 2015 22 799 810 10.1016/j.cmet.2015.09.012 26456334 PMC4635034 · DOI
- [19]Sato K Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction J. Exp. Med 2006 203 2673 2682 10.1084/jem.20061775 17088434 PMC2118166 · DOI · Paper page
- [22]Li Jau-Yi Yu Mingcan Tyagi Abdul Malik Vaccaro Chiara Hsu Emory Adams Jonathan Bellido Teresita Weitzmann M Neale Pacifici Roberto IL-17 Receptor Signaling in Osteoblasts/Osteocytes Mediates PTH-Induced Bone Loss and Enhances Osteocytic RANKL Production Journal of Bone and Mineral Research 2018 34 2 349 360 10.1002/jbmr.3600 30399207 · DOI
- [23]Adamopoulos, I. E., et al. Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors. Arthritis. Res. Ther.12, R29 (2010). PMC2875663 20167120
- [24]Okamoto K Takayanagi H Osteoclasts in arthritis and Th17 cell development Int. Immunopharmacol. 2011 11 543 548 10.1016/j.intimp.2010.11.010 21081190 · DOI
- [25]Uluckan O Chronic skin inflammation leads to bone loss by IL-17-mediated inhibition of Wnt signaling in osteoblasts Sci. Transl. Med 2016 8 330ra337 10.1126/scitranslmed.aad8996 27089206 · DOI
- [26]Shaw AT Maeda Y Gravallese EM IL-17A deficiency promotes periosteal bone formation in a model of inflammatory arthritis Arthritis Res Ther. 2016 18 104 10.1186/s13075-016-0998-x 27165410 PMC4863346 · DOI
- [27]Schirmer M Linking the human gut microbiome to inflammatory cytokine production capacity Cell 2016 167 1125 1136 10.1016/j.cell.2016.10.020 27814509 PMC5131922 · DOI
- [28]Ivanov II Induction of intestinal Th17 cells by segmented filamentous bacteria Cell 2009 139 485 498 10.1016/j.cell.2009.09.033 19836068 PMC2796826 · DOI · Paper page
- [30]Gaboriau-Routhiau V The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses Immunity 2009 31 677 689 10.1016/j.immuni.2009.08.020 19833089 · DOI · Paper page
- [31]Yang Y Focused specificity of intestinal TH17 cells towards commensal bacterial antigens Nature 2014 510 152 156 10.1038/nature13279 24739972 PMC4128479 · DOI · Paper page
- [33]Bradley CP Segmented filamentous bacteria provoke lung autoimmunity by inducing gut-lung axis Th17 cells expressing dual TCRs Cell host microbe 2017 22 697 704 10.1016/j.chom.2017.10.007 29120746 PMC5749641 · DOI
- [34]Krebs CF Autoimmune renal disease is exacerbated by S1P-receptor-1-dependent intestinal Th17 cell migration to the kidney Immunity 2016 45 1078 1092 10.1016/j.immuni.2016.10.020 27851911 PMC6381450 · DOI
- [35]Acosta-Rodriguez EV Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells Nat. Immunol. 2007 8 639 646 10.1038/ni1467 17486092 · DOI · Paper page
- [36]Baeyens A Fang V Chen C Schwab SR Exit strategies: S1P signaling and T cell migration Trends Immunol. 2015 36 778 787 10.1016/j.it.2015.10.005 26596799 PMC4832571 · DOI
- [37]Brinkmann V FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression Transpl. Proc. 2001 33 530 531 10.1016/S0041-1345(00)02126-6 11266942 · DOI
- [38]Chun J Hartung HP Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis Clin. Neuropharmacol. 2010 33 91 101 10.1097/WNF.0b013e3181cbf825 20061941 PMC2859693 · DOI · Paper page
- [39]Turner JE CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis J. Am. Soc. Nephrol. 2010 21 974 985 10.1681/ASN.2009070741 20299360 PMC2900961 · DOI
- [40]Marelli-Berg FM Cannella L Dazzi F Mirenda V The highway code of T cell trafficking J. Pathol. 2008 214 179 189 10.1002/path.2269 18161751 · DOI
- [41]Martinez GJ Nurieva RI Yang XO Dong C Regulation and function of proinflammatory TH17 cells Ann. N. Y Acad. Sci. 2008 1143 188 211 10.1196/annals.1443.021 19076351 PMC5793850 · DOI
- [42]Komatsu N Takayanagi H Autoimmune arthritis: the interface between the immune system and joints Adv. Immunol. 2012 115 45 71 10.1016/B978-0-12-394299-9.00002-3 22608255 · DOI
- [43]Waisman A T helper cell populations: as flexible as the skin? Eur. J. Immunol. 2011 41 2539 2543 10.1002/eji.201141938 21952814 · DOI
- [44]Jovanovic DV IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages J. Immunol. 1998 160 3513 3521 9531313
- [45]Tsukasaki M Host defense against oral microbiota by bone-damaging T cells Nat. Commun. 2018 9 701 10.1038/s41467-018-03147-6 29453398 PMC5816021 · DOI
- [46]Mangan PR Transforming growth factor-beta induces development of the T(H)17 lineage Nature 2006 441 231 234 10.1038/nature04754 16648837 · DOI · Paper page
- [47]Ghoreschi K Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling Nature 2010 467 967 971 10.1038/nature09447 20962846 PMC3108066 · DOI · Paper page
- [49]Bondar C Role of Cxcr3/CXCL10 axis in immune cell recruitment into the small intestine in celiac disease PLoS ONE 2014 9 e89068 10.1371/journal.pone.0089068 24586509 PMC3930692 · DOI · Paper page
- [50]Ma YL Catabolic effects of continuous human PTH (1–38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation Endocrinology 2001 142 4047 4054 10.1210/endo.142.9.8356 11517184 · DOI · Paper page
- [51]Farkas AM Induction of Th17 cells by segmented filamentous bacteria in the murine intestine J. Immunol. Methods 2015 421 104 111 10.1016/j.jim.2015.03.020 25858227 PMC4764030 · DOI
- [52]Lang H Faller H Schilling S [Coping with disease from the psychosomatic-psychotherapeutic viewpoint exemplified by pancreatectomized patients] Psychother. Psychosom. Med. Psychol. 1989 39 239 247 2762478
- [53]Schnupf P Growth and host interaction of mouse segmented filamentous bacteria in vitro Nature 2015 520 99 103 10.1038/nature14027 25600271 PMC5102327 · DOI
- [54]Rakoff-Nahoum S Paglino J Eslami-Varzaneh F Edberg S Medzhitov R Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis Cell 2004 118 229 241 10.1016/j.cell.2004.07.002 15260992 · DOI · Paper page
- [55]Lefrancois, L. & Lycke, N. Isolation of mouse small intestinal intraepithelial lymphocytes, Peyer’s patch, and lamina propria cells. Curr. Protoc. Immunol. Chapter 3, Unit 3 19 (2001). 18432783
- [56]Bedi B Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH Proc. Natl Acad. Sci. USA 2012 109 E725 E733 10.1073/pnas.1120735109 22393015 PMC3311391 · DOI
- [57]Li JY The sclerostin-independent bone anabolic activity of intermittent PTH treatment is mediated by T-cell-produced Wnt10b J. Bone Min. Res. 2014 29 43 54 10.1002/jbmr.2044 PMC4326235 24357520 · DOI
- [58]Robinson JW T cell-expressed CD40L potentiates the bone anabolic activity of intermittent PTH treatment J. Bone Min. Res. 2015 30 695 705 10.1002/jbmr.2394 PMC4376617 25359628 · DOI
- [59]Bouxsein ML Guidelines for assessment of bone microstructure in rodents using micro-computed tomography J. Bone Min. Res. 2010 25 1468 1486 10.1002/jbmr.141 20533309 · DOI
Cited by
Sorted by citations
Advances in pathogenesis and therapeutic strategies for osteoporosis
Song, S., Guo, Y., Yang, Y., & Fu, D. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108168 · Cited by 476 · see citing works
Modulation of bone remodeling by the gut microbiota: A new therapy for osteoporosis
Lyu, Z., Hu, Y., Guo, Y., & Liu, D. (2023) · Bone Research · doi:10.1038/s41413-023-00264-x · Cited by 207 · see citing works
Callus γδ T cells and microbe-induced intestinal Th17 cells improve fracture healing in mice
Dar, H. Y., Perrien, D. S., Pal, S., Stoica, A., Uppuganti, S., Nyman, J. S., Jones, R. M., Weitzmann, M. N., & Pacifici, R. (2023) · Journal of Clinical Investigation · doi:10.1172/jci166577 · Cited by 48 · see citing works
Self-citationGan, D., Qin, L., & Xiao, G. (2026) · Research · doi:10.34133/research.1319 · Cited by 1 · see citing works
“…such as segmented filamentous bacteria enhance Th17-associated inflammatory signaling and may thereby facilitate osteoclastogenic bone resorption [ 60 ], whereas reductions in SCFA production weaken regulatory T cell-mediated bone-protective programs and shift the balance toward bone resorption […”
- Authors
- Yu, M., Malik Tyagi, A., Li, J.-Y., Adams, J., Denning, T. L., Weitzmann, M. N., Jones, R. M., & Pacifici, R.
- Affiliations
- Emory University (US)
- Georgia State University (US)
- Corresponding author
- Pacifici, Roberto
- Venue
- Nature Communications
- Published
- 2020-01-24
- Volume
- 11
- Issue
- 1
- Pages
- 468-468
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC6981196
- OpenAlex
- W3002574702
- Cited by
- 148
- References
- 6
- Citations by year
- 2026: 26 · 2025: 19 · 2024: 23 · 2023: 25 · 2022: 14 · 2021: 28 · 2020: 12 · 2018: 1
- FWCI
- 6.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- U.S. Department of Health & Human Services | National Institutes of Health (DK112946, DK108842, RR028009, DK098391, AG062334)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- parathyroid hormone, hyperparathyroidism, bone loss, gut microbiota, segmented filamentous bacteria, Th17 cells, intestinal T cells, S1P1 receptor, CXCR3, CCL20, bone marrow homing, germ-free mice, antibiotic-treated mice
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Animals, Female, Germ-Free Life, Intestines, Mice, Inbred C57BL, Osteoporosis, Parathyroid Hormone, Tumor Necrosis Factor-alpha, T-Lymphocyte Subsets, Gram-Positive Endospore-Forming Rods, Mice, Knockout, Hyperparathyroidism, Primary, Mice, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review